100% Quality Guarantee
PhD-Level Technical Support
Human CLK3 Recombinant Protein (N-His)
Key Features

Human CLK3 Recombinant Protein (N-His) (GXRP11329)

SKU GXRP11329
Product Type Recombinant Protein
Species Human
Expression System E. coli
Tag N-His
€347 - €1,827

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human CLK3 Recombinant Protein (N-His)

Human CLK3 Recombinant Protein (N-His) is a recombinant protein expressed in E. coli, spanning Ile296-Arg638, with an N-terminal His tag. Predicted molecular weight: 42.64 kDa. Purity: >90% as determined by SDS-PAGE. Supplied lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Applications: ELISA, immunogen, SDS-PAGE and Western blot. Dual specificity protein kinase CLK3 is a ~58 kDa protein. Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. For research use only.

Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose